Skip to main content

Surgical Concepts and Considerations of Inguinal Lymph Node Dissection for Penile Cancer

  • Chapter
  • First Online:
  • 813 Accesses

Part of the book series: Current Clinical Urology ((CCU))

Abstract

The pattern of metastasis for penile cancer occurs in a predictable fashion, first spreading to the inguinal lymph nodes (ILN) and then to the pelvic nodes. Paramount to proper patient management is early identification and treatment of metastases, especially in the patient that presents with palpable disease. A proper metastatic workup will assist in determining the best way to move forward with either an ILN dissection or a multimodality approach to provide the most favorable outcomes. Several advances have been made in the surgical techniques that have helped minimize the morbidity associated with an ILN dissection.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Slaton JW, Morgenstern N, Levy DA, Santos Jr MW, Tamboli P, Ro JY, et al. Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. J Urol. 2001;165(4):1138–42.

    Article  PubMed  CAS  Google Scholar 

  2. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer. 2005;116(4):606–16.

    Article  PubMed  CAS  Google Scholar 

  3. Horenblas S, van Tinteren H, Delemarre JF, Moonen LM, Lustig V, van Waardenburg EW. Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J Urol. 1993;149(3):492–7.

    PubMed  CAS  Google Scholar 

  4. Pizzocaro G, Algaba F, Horenblas S, Solsona E, Tana S, Van Der Poel H, et al. EAU penile cancer guidelines 2009. Eur Urol. 2010;57(6):1002–12.

    Article  PubMed  Google Scholar 

  5. Stancik I, Holtl W. Penile cancer: review of the recent literature. Curr Opin Urol. 2003;13(6):467–72.

    Article  PubMed  Google Scholar 

  6. Kroon BK, Horenblas S, Lont AP, Tanis PJ, Gallee MP, Nieweg OE. Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. J Urol. 2005;173(3):816–9.

    Article  PubMed  CAS  Google Scholar 

  7. Svatek RS, Munsell M, Kincaid JM, Hegarty P, Slaton JW, Busby JE, et al. Association between lymph node density and disease specific survival in patients with penile cancer. J Urol. 2009;182(6):2721–7.

    Article  PubMed  Google Scholar 

  8. Pettaway C, Lynch Jr D, Davis J. Tumors of the penis. In: Wein AJ, Kavoussi L, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 9th ed. Philadelphia: Saunders; 2007. p. 959–92.

    Google Scholar 

  9. Daseler EH, Anson BJ, Reimann AF. Radical excision of the inguinal and iliac lymph glands; a study based upon 450 anatomical dissections and upon supportive clinical observations. Surg Gynecol Obstet. 1948;87(6):679–94.

    PubMed  CAS  Google Scholar 

  10. Sharp DS, Angermeier KW. Surgery of penile and urethral carcinoma. In: Wein AJ, Kavoussi L, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 9th ed. Philadelphia: Saunders; 2007. p. 993–1022.

    Google Scholar 

  11. Heyns CF, Fleshner N, Sangar V, Schlenker B, Yuvaraja TB, van Poppel H. Management of the lymph nodes in penile cancer. Urology. 2010;76(2 Suppl 1):S43–57.

    Article  PubMed  Google Scholar 

  12. Loughlin KR. Surgical atlas. Surgical management of penile carcinoma: the inguinal nodes. BJU Int. 2006;97(5):1125–34.

    Article  PubMed  Google Scholar 

  13. Wood HM, Angermeier KW. Anatomic considerations of the penis, lymphatic drainage, and biopsy of the sentinel node. Urol Clin North Am. 2010;37(3):327–34.

    Article  PubMed  Google Scholar 

  14. Protzel C, Alcaraz A, Horenblas S, Pizzocaro G, Zlotta A, Hakenberg OW. Lymphadenectomy in the surgical management of penile cancer. Eur Urol. 2009;55(5):1075–88.

    Article  PubMed  Google Scholar 

  15. Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penis. Part 1: diagnosis of lymph node metastasis. BJU Int. 2001;88(5):467–72.

    Article  PubMed  CAS  Google Scholar 

  16. Kroon BK, Valdes Olmos RA, van Tinteren H, Nieweg OE, Horenblas S. Reproducibility of lymphoscintigraphy for lymphatic mapping in patients with penile carcinoma. J Urol. 2005;174(6):2214–7.

    Article  PubMed  Google Scholar 

  17. Srinivas V, Morse MJ, Herr HW, Sogani PC, Whitmore Jr WF. Penile cancer: relation of extent of nodal metastasis to survival. J Urol. 1987;137(5):880–2.

    PubMed  CAS  Google Scholar 

  18. Pow-Sang JE, Benavente V, Pow-Sang JM, Pow-Sang M. Bilateral ilioinguinal lymph node dissection in the management of cancer of the penis. Semin Surg Oncol. 1990;6(4):241–2.

    Article  PubMed  CAS  Google Scholar 

  19. Ravi R. Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol. 1993;72(5 Pt 2):817–9.

    Article  PubMed  CAS  Google Scholar 

  20. Sanchez-Ortiz RF, Pettaway CA. The role of lymphadenectomy in penile cancer. Urol Oncol. 2004;22(3):236–44. discussion 44–5.

    Article  PubMed  Google Scholar 

  21. Lopes A, Bezerra AL, Serrano SV, Hidalgo GS. Iliac nodal metastases from carcinoma of the penis treated surgically. BJU Int. 2000;86(6):690–3.

    Article  PubMed  CAS  Google Scholar 

  22. Leijte JA, Kirrander P, Antonini N, Windahl T, Horenblas S. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol. 2008;54(1):161–8.

    Article  PubMed  Google Scholar 

  23. Culkin DJ, Beer TM. Advanced penile carcinoma. J Urol. 2003;170(2 Pt 1):359–65.

    Article  PubMed  Google Scholar 

  24. Lont AP, Kroon BK, Gallee MP, van Tinteren H, Moonen LM, Horenblas S. Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival. J Urol. 2007;177(3):947–52. discussion 52.

    Article  PubMed  Google Scholar 

  25. Campbell MF, Wein AJ, Kavoussi LR. Campbell-Walsh urology. In: Alan J. Wein, Louis R. Kavoussi, editors. 9th ed. Philadelphia: Saunders; 2007. p. 4 v. (xlii, 3945, cxv p.).

    Google Scholar 

  26. Ficarra V, Akduman B, Bouchot O, Palou J, Tobias-Machado M. Prognostic factors in penile cancer. Urology. 2010;76(2 Suppl 1):S66–73.

    Article  PubMed  Google Scholar 

  27. Margulis V, Sagalowsky AI. Penile cancer: management of regional lymphatic drainage. Urol Clin North Am. 2010;37(3):411–9.

    Article  PubMed  Google Scholar 

  28. Hadway P, Smith Y, Corbishley C, Heenan S, Watkin NA. Evaluation of dynamic lymphoscintigraphy and sentinel lymph-node biopsy for detecting occult metastases in patients with penile squamous cell carcinoma. BJU Int. 2007;100(3):561–5.

    Article  PubMed  Google Scholar 

  29. Hughes B, Leijte J, Shabbir M, Watkin N, Horenblas S. Non-invasive and minimally invasive staging of regional lymph nodes in penile cancer. World J Urol. 2009;27(2):197–203.

    Article  PubMed  Google Scholar 

  30. Kroon BK, Horenblas S, Deurloo EE, Nieweg OE, Teertstra HJ. Ultrasonography-guided fine-needle aspiration cytology before sentinel node biopsy in patients with penile carcinoma. BJU Int. 2005;95(4):517–21.

    Article  PubMed  Google Scholar 

  31. Leijte JA, Horenblas S. Shortcomings of the current TNM classification for penile carcinoma: time for a change? World J Urol. 2009;27(2):151–4.

    Article  PubMed  Google Scholar 

  32. The National Cancer Institute, Penile Cancer Treatment. [cited 2012]; Available from: http://www.cancer.gov/cancertopics/types/penile.

  33. Edge SB, Byrd DR, Compton CC, More A, More A, More A, et al. Penis. In: Edge SB, Byrd DR, Compton CC, More A, More A, More A, et al., editors. AJCC cancer staging manual. 7th ed. New York, NY: Springer; 2010. p. 449–50.

    Google Scholar 

  34. Barocas DA, Chang SS. Penile cancer: clinical presentation, diagnosis, and staging. Urol Clin North Am. 2010;37(3):343–52.

    Article  PubMed  Google Scholar 

  35. Sobin LH, Wittekind C. International Union against cancer. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss; 2002.

    Google Scholar 

  36. Leijte JA, Gallee M, Antonini N, Horenblas S. Evaluation of current TNM classification of penile carcinoma. J Urol. 2008;180(3):933–8. discussion 8.

    Article  PubMed  Google Scholar 

  37. Velazquez EF, Ayala G, Liu H, Chaux A, Zanotti M, Torres J, et al. Histologic grade and perineural invasion are more important than tumor thickness as predictor of nodal metastasis in penile squamous cell carcinoma invading 5 to 10 mm. Am J Surg Pathol. 2008;32(7):974–9.

    Article  PubMed  Google Scholar 

  38. Bhagat SK, Gopalakrishnan G, Kekre NS, Chacko NK, Kumar S, Manipadam MT, et al. Factors predicting inguinal node metastasis in squamous cell cancer of penis. World J Urol. 2010;28(1):93–8.

    Article  PubMed  Google Scholar 

  39. Solsona E, Iborra I, Rubio J, Casanova JL, Ricos JV, Calabuig C. Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. J Urol. 2001;165(5):1506–9.

    Article  PubMed  CAS  Google Scholar 

  40. Ficarra V, Zattoni F, Artibani W, Fandella A, Martignoni G, Novara G, et al. Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis. J Urol. 2006;175(5):1700–4. discussion 4–5.

    Article  PubMed  Google Scholar 

  41. Kattan MW, Ficarra V, Artibani W, Cunico SC, Fandella A, Martignoni G, et al. Nomogram predictive of cancer specific survival in patients undergoing partial or total amputation for squamous cell carcinoma of the penis. J Urol. 2006;175(6):2103–8. discussion 8.

    Article  PubMed  Google Scholar 

  42. Novara G, Galfano A, De Marco V, Artibani W, Ficarra V. Prognostic factors in squamous cell carcinoma of the penis. Nat Clin Pract Urol. 2007;4(3):140–6.

    Article  PubMed  Google Scholar 

  43. Scher B, Seitz M, Albinger W, Reiser M, Schlenker B, Stief C, et al. Value of PET and PET/CT in the diagnostics of prostate and penile cancer. Recent Results Cancer Res. 2008;170:159–79.

    Article  PubMed  CAS  Google Scholar 

  44. Schlenker B, Scher B, Tiling R, Siegert S, Hungerhuber E, Gratzke C, et al. Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET/CT: A prospective single-center study. Urol Oncol. 2009

    Google Scholar 

  45. Mueller-Lisse UG, Scher B, Scherr MK, Seitz M. Functional imaging in penile cancer: PET/computed tomography, MRI, and sentinel lymph node biopsy. Curr Opin Urol. 2008;18(1):105–10.

    Article  PubMed  Google Scholar 

  46. Scher B, Seitz M, Reiser M, Hungerhuber E, Hahn K, Tiling R, et al. 18F-FDG PET/CT for staging of penile cancer. J Nucl Med. 2005;46(9):1460–5.

    PubMed  Google Scholar 

  47. Tabatabaei S, Harisinghani M, McDougal WS. Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer. J Urol. 2005;174(3):923–7. discussion 7.

    Article  PubMed  Google Scholar 

  48. Caso JR, Rodriguez AR, Correa J, Spiess PE. Update in the management of penile cancer. Int Braz J Urol. 2009;35(4):406–15.

    Article  PubMed  Google Scholar 

  49. Souillac I, Rigaud J, Ansquer C, Marconnet L, Bouchot O. Prospective evaluation of (18)F-fluorodeoxyglucose positron emission tomography-computerized tomography to assess inguinal lymph node status in invasive squamous cell carcinoma of the penis. J Urol. 2012;187(2):493–7.

    Article  PubMed  Google Scholar 

  50. Graafland NM, Valdes Olmos RA, Teertstra HJ, Kerst JM, Bergman AM, Horenblas S. 18F-FDG PET/CT for monitoring induction chemotherapy in patients with primary inoperable penile carcinoma: first clinical results. Eur J Nucl Med Mol Imaging. 2010;37(8):1474–80.

    Article  PubMed  CAS  Google Scholar 

  51. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39(2):456–66.

    Article  PubMed  CAS  Google Scholar 

  52. Pettaway CA, Pisters LL, Dinney CP, Jularbal F, Swanson DA, von Eschenbach AC, et al. Sentinel lymph node dissection for penile carcinoma: the M.D. Anderson Cancer Center experience. J Urol. 1995;154(6):1999–2003.

    Article  PubMed  CAS  Google Scholar 

  53. Wespes E, Simon J, Schulman CC. Cabanas approach: is sentinel node biopsy reliable for staging penile carcinoma? Urology. 1986;28(4):278–9.

    Article  PubMed  CAS  Google Scholar 

  54. Leijte JA, Kroon BK, Valdes Olmos RA, Nieweg OE, Horenblas S. Reliability and safety of current dynamic sentinel node biopsy for penile carcinoma. Eur Urol. 2007;52(1):170–7.

    Article  PubMed  Google Scholar 

  55. Valdes Olmos RA, Tanis PJ, Hoefnagel CA, Jansen L, Nieweg OE, Meinhardt W, et al. Penile lymphoscintigraphy for sentinel node identification. Eur J Nucl Med. 2001;28(5):581–5.

    Article  PubMed  CAS  Google Scholar 

  56. Kroon BK, Horenblas S, Meinhardt W, van der Poel HG, Bex A, van Tinteren H, et al. Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10 years experience. Eur Urol. 2005;47(5):601–6. discussion 6.

    Article  PubMed  Google Scholar 

  57. Tanis PJ, Lont AP, Meinhardt W, Olmos RA, Nieweg OE, Horenblas S. Dynamic sentinel node biopsy for penile cancer: reliability of a staging technique. J Urol. 2002;168(1):76–80.

    Article  PubMed  CAS  Google Scholar 

  58. Gonzaga-Silva LF, Tavares JM, Freitas FC, Tomas Filho ME, Oliveira VP, Lima MV. The isolated gamma probe technique for sentinel node penile carcinoma detection is unreliable. Int Braz J Urol. 2007;33(1):58–63. discussion 4–7.

    Article  PubMed  Google Scholar 

  59. Spiess PE, Izawa JI, Bassett R, Kedar D, Busby JE, Wong F, et al. Preoperative lymphoscintigraphy and dynamic sentinel node biopsy for staging penile cancer: results with pathological correlation. J Urol. 2007;177(6):2157–61.

    Article  PubMed  Google Scholar 

  60. Kroon BK, Horenblas S, Estourgie SH, Lont AP, Valdes Olmos RA, Nieweg OE. How to avoid false-negative dynamic sentinel node procedures in penile carcinoma. J Urol. 2004;171(6 Pt 1):2191–4.

    Article  PubMed  CAS  Google Scholar 

  61. Lont AP, Horenblas S, Tanis PJ, Gallee MP, van Tinteren H, Nieweg OE. Management of clinically node negative penile carcinoma: improved survival after the introduction of dynamic sentinel node biopsy. J Urol. 2003;170(3):783–6.

    Article  PubMed  CAS  Google Scholar 

  62. Kroon BK, Lont AP, Valdes Olmos RA, Nieweg OE, Horenblas S. Morbidity of dynamic sentinel node biopsy in penile carcinoma. J Urol. 2005;173(3):813–5.

    Article  PubMed  CAS  Google Scholar 

  63. Ficarra V, Galfano A. Should the dynamic sentinel node biopsy (DSNB) be considered the gold standard in the evaluation of lymph node status in patients with penile carcinoma? Eur Urol. 2007;52(1):17–9. discussion 20-1.

    Article  PubMed  Google Scholar 

  64. Catalona WJ. Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous veins: technique and preliminary results. J Urol. 1988;140(2):306–10.

    PubMed  CAS  Google Scholar 

  65. Lopes A, Rossi BM, Fonseca FP, Morini S. Unreliability of modified inguinal lymphadenectomy for clinical staging of penile carcinoma. Cancer. 1996;77(10):2099–102.

    Article  PubMed  CAS  Google Scholar 

  66. Bermejo C, Busby JE, Spiess PE, Heller L, Pagliaro LC, Pettaway CA. Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol. 2007;177(4):1335–8.

    Article  PubMed  Google Scholar 

  67. Pagliaro LC, Crook J. Multimodality therapy in penile cancer: when and which treatments? World J Urol. 2009;27(2):221–5.

    Article  PubMed  CAS  Google Scholar 

  68. Ornellas AA. Management of penile cancer. J Surg Oncol. 2008;97(3):199–200.

    Article  PubMed  Google Scholar 

  69. Ornellas AA, Seixas AL, de Moraes JR. Analyses of 200 lymphadenectomies in patients with penile carcinoma. J Urol. 1991;146(2):330–2.

    PubMed  CAS  Google Scholar 

  70. Ravi R. Morbidity following groin dissection for penile carcinoma. Br J Urol. 1993;72(6):941–5.

    Article  PubMed  CAS  Google Scholar 

  71. Bouchot O, Rigaud J, Maillet F, Hetet JF, Karam G. Morbidity of inguinal lymphadenectomy for invasive penile carcinoma. Eur Urol. 2004;45(6):761–5. discussion 5–6.

    Article  PubMed  Google Scholar 

  72. Yao K, Tu H, Li YH, Qin ZK, Liu ZW, Zhou FJ, et al. Modified technique of radical inguinal lymphadenectomy for penile carcinoma: morbidity and outcome. J Urol. 2010;184(2):546–52.

    Article  PubMed  Google Scholar 

  73. Zhang Q, Qiao Q, Gould LJ, Myers WT, Phillips LG. Study of the neural and vascular anatomy of the anterolateral thigh flap. J Plast Reconstr Aesthet Surg. 2010;63(2):365–71.

    Article  PubMed  Google Scholar 

  74. Kean J, Hough M, Stevenson JH. Skin excision and groin lymphadenectomy: techniques and outcomes. Lymphology. 2006;39(3):141–6.

    PubMed  CAS  Google Scholar 

  75. Crawford ED, Daneshgari F. Management of regional lymphatic drainage in carcinoma of the penis. Urol Clin North Am. 1992;19(2):305–17.

    PubMed  CAS  Google Scholar 

  76. Spiess PE, Hernandez MS, Pettaway CA. Contemporary inguinal lymph node dissection: minimizing complications. World J Urol. 2009;27(2):205–12.

    Article  PubMed  Google Scholar 

  77. Tobias-Machado M, Tavares A, Silva MN, Molina Jr WR, Forseto PH, Juliano RV, et al. Can video endoscopic inguinal lymphadenectomy achieve a lower morbidity than open lymph node dissection in penile cancer patients? J Endourol. 2008;22(8):1687–91.

    Article  PubMed  Google Scholar 

  78. Tobias-Machado M, Tavares A, Ornellas AA, Molina Jr WR, Juliano RV, Wroclawski ER. Video endoscopic inguinal lymphadenectomy: a new minimally invasive procedure for radical management of inguinal nodes in patients with penile squamous cell carcinoma. J Urol. 2007;177(3):953–7. discussion 8.

    Article  PubMed  Google Scholar 

  79. Tobias-Machado M, Tavares A, Molina Jr WR, Forseto Jr PH, Juliano RV, Wroclawski ER. Video endoscopic inguinal lymphadenectomy (VEIL): minimally invasive resection of inguinal lymph nodes. Int Braz J Urol. 2006;32(3):316–21.

    Article  PubMed  CAS  Google Scholar 

  80. Bishoff JT, Lackland AFB, Basler JW, Teichman JM, Thompson IM. Endoscopic subcutaneous modified inguinal lymph node dissection (ESMIL) for squamous cell carcinoma of the penis. J Urol. 2003;169:78.

    Article  Google Scholar 

  81. Sotelo R, Sanchez-Salas R, Clavijo R. Endoscopic inguinal lymph node dissection for penile carcinoma: the developing of a novel technique. World J Urol. 2009;27(2):213–9.

    Article  PubMed  Google Scholar 

  82. Sotelo R, Sanchez-Salas R, Carmona O, Garcia A, Mariano M, Neiva G, et al. Endoscopic lymphadenectomy for penile carcinoma. J Endourol. 2007;21(4):364–7. discussion 7.

    Article  PubMed  Google Scholar 

  83. Bevan-Thomas R, Slaton JW, Pettaway CA. Contemporary morbidity from lymphadenectomy for penile squamous cell carcinoma: the M.D. Anderson Cancer Center Experience. J Urol. 2002;167(4):1638–42.

    Article  PubMed  Google Scholar 

  84. Nelson BA, Cookson MS, Smith Jr JA, Chang SS. Complications of inguinal and pelvic lymphadenectomy for squamous cell carcinoma of the penis: a contemporary series. J Urol. 2004;172(2):494–7.

    Article  PubMed  Google Scholar 

  85. Jacobellis U. Modified radical inguinal lymphadenectomy for carcinoma of the penis: technique and results. J Urol. 2003;169(4):1349–52.

    Article  PubMed  Google Scholar 

  86. Parra RO. Accurate staging of carcinoma of the penis in men with nonpalpable inguinal lymph nodes by modified inguinal lymphadenectomy. J Urol. 1996;155(2):560–3.

    Article  PubMed  CAS  Google Scholar 

  87. Ayyappan K, Ananthakrishnan N, Sankaran V. Can regional lymph node involvement be predicted in patients with carcinoma of the penis? Br J Urol. 1994;73(5):549–53.

    Article  PubMed  CAS  Google Scholar 

  88. Ornellas AA, Kinchin EW, Nobrega BL, Wisnescky A, Koifman N, Quirino R. Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience. J Surg Oncol. 2008;97(6):487–95.

    Article  PubMed  Google Scholar 

  89. d’Ancona CA, de Lucena RG, Querne FA, Martins MH, Denardi F, Netto Jr NR. Long-term followup of penile carcinoma treated with penectomy and bilateral modified inguinal lymphadenectomy. J Urol. 2004;172(2):498–501. discussion.

    Article  PubMed  Google Scholar 

  90. Coblentz TR, Theodorescu D. Morbidity of modified prophylactic inguinal lymphadenectomy for squamous cell carcinoma of the penis. J Urol. 2002;168(4 Pt 1):1386–9.

    PubMed  Google Scholar 

  91. Ettema HB, Kollen BJ, Verheyen CC, Buller HR. Prevention of venous thromboembolism in patients with immobilization of the lower extremities: a meta-analysis of randomized controlled trials. J Thromb Haemost. 2008;6(7):1093–8.

    Article  PubMed  CAS  Google Scholar 

  92. Sawczuk IS, Williams D, Chang DT. Low molecular weight heparin for venous thromboembolism prophylaxis in urologic oncologic surgery. Cancer Invest. 2002;20(7–8):889–92.

    Article  PubMed  CAS  Google Scholar 

  93. Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: the role and technique of lymph node dissection. BJU Int. 2001;88(5):473–83.

    Article  PubMed  CAS  Google Scholar 

  94. Darouiche RO, Wall Jr MJ, Itani KM, Otterson MF, Webb AL, Carrick MM, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med. 2010;362(1):18–26.

    Article  PubMed  CAS  Google Scholar 

  95. Gallo Rolania FJ, Beneitez Alvarez ME, Izquierdo Garcia FM. The role of inguinal lymphadenectomy in epidermoid carcinoma of the penis. Use of Ligasure and analysis of the results. Arch Esp Urol. 2002;55(5):535–8.

    PubMed  Google Scholar 

  96. Orefice S, Conti AR, Grassi M, Salvadori B. The use of lympho-venous anastomoses to prevent complications from ilio-inguinal dissection. Tumori. 1988;74(3):347–51.

    PubMed  CAS  Google Scholar 

  97. Bare RL, Assimos DG, McCullough DL, Smith DP, DeFranzo AJ, Marks MW. Inguinal lymphadenectomy and primary groin reconstruction using rectus abdominis muscle flaps in patients with penile cancer. Urology. 1994;44(4):557–61.

    Article  PubMed  CAS  Google Scholar 

  98. Tabatabaei S, McDougal WS. Primary skin closure of large groin defects after inguinal lymphadenectomy for penile cancer using an abdominal cutaneous advancement flap. J Urol. 2003;169(1):118–20.

    Article  PubMed  Google Scholar 

  99. Graafland NM, Moonen LM, van Boven HH, van Werkhoven E, Kerst JM, Horenblas S. Inguinal recurrence following therapeutic lymphadenectomy for node positive penile carcinoma: outcome and implications for management. J Urol. 2011;185(3):888–93.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philippe E. Spiess M.D., M.S. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ercole, C.E., Spiess, P.E. (2013). Surgical Concepts and Considerations of Inguinal Lymph Node Dissection for Penile Cancer. In: Spiess, P. (eds) Penile Cancer. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-367-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-367-1_6

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-366-4

  • Online ISBN: 978-1-62703-367-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics